Mountain Region Family Medicine, Pc

CLIA Laboratory Citation Details

3
Total Citations
10
Total Deficiencyies
10
Unique D-Tags
CMS Certification Number 44D0311095
Address 444 Clinchfield Street, Suite 2300, Kingsport, TN, 37660
City Kingsport
State TN
Zip Code37660
Phone(423) 230-2801

Citation History (3 surveys)

Survey - July 23, 2024

Survey Type: Standard

Survey Event ID: QMSD11

Deficiency Tags: D5403 D5401

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review of the laboratory's Quality Assurance Plan, review of proficiency testing records, and staff interviews, the laboratory failed to follow its written policy for proficiency testing result review in 2023 and 2024. The findings include: 1. A review of the laboratory's Quality Assurance Plan revealed the following statement, "We will evaluate the results of our proficiency testing (PT) with the laboratory director within one week of their return from the PT program." 2. A review of the proficiency testing records for 2023 3rd Event and 2024 1st Event revealed missing final evaluation results for both events. 3. Interview on 07.23.2024 at 12:30 p.m. with the Technical Consultant and Lab Manager confirmed the above survey findings. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 3, 2020

Survey Type: Standard

Survey Event ID: JGU111

Deficiency Tags: D5791 D6053 D5415 D6015 D2009 D6054

Summary:

Summary Statement of Deficiencies D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: ==================================== Based on review of 2018 and 2019 Proficiency Testing (PT) attestation sheets and upon interview with the MLT Supervisor, it was determined the laboratory director failed to sign the attestation sheets for Chemistry, Hematology and Clinical Microscopy for the two year period. The findings include: 1. The laboratory director failed to sign the PT attestation sheets for 2018 and 2019 for Chemistry, Hematology and Clinical Microscopy. 2. An interview at approximately 3:00 p.m. on 1/27/2020 with the MLT Supervisor confirmed the laboratory director had not signed the attestation sheets for the two year period. ==================================== D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: =================================== Based on observation of Chemistry Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- and Hematology control materials at 9:30 a.m. on January 27, 2020 and an interview with the Medical Laboratory Technician (MLT) Supervisor, it was determined the laboratory failed to document open date expiration dates for the Chemistry and CBC controls in use. The findings include: 1. Observation at 9:30 a.m. on January 27, 2020 of control materials in use for Chemistry and CBC testing revealed no open dates or expiration dates documented. 2. An interview at 9:30 a.m. on January 27, 2020, with the MLT Supervisor, confirmed the Chemistry and CBC control materials that were in use, did not have open dates or expirations dates documented. ===================================== D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: ==================================== Based on Quality Assessment (QA) policy stating the Laboratory Director is to review the analyic systems monthly, lack of CBC Quality Control (QC) reviews from October 2018 to December 2019 and an interview with the MLT Supervisor, it was determined the Laboratory Director failed to follow QA policy for monthly CBC QC reviews since October 2018. The findings include: 1. The Quality Assessment policy states the Laboratory Director is to review analytic systems monthly. 2. There was no documentation of CBC QC reviews from October 2018 to December 2019. 3. An interview at approximately 3:00 p.m. on January 27, 2020 with the MLT Supervisor confirmed the Laboratory Director had not reviewed the CBC quality controls since October 2018. ====================================== D6015 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4) Ensure that the laboratory is enrolled in an HHS approved proficiency testing program for the testing performed. This STANDARD is not met as evidenced by: ==================================== Based on lack of documentation for Proficiency Testing (PT) order confirmation for 2020 for Chemistry, Hematology and Clinical Microscopy and an interview with the MLT Supervisor, it was determined the laboratory director failed to ensure that Proficiency Testing for 2020 had been re-ordered. The findings include: 1. There was no PT order confirmation for 2020 for testing performed to include Chemistry, Hematology and Clinical Microscopy. 2. An interview at approximately 3:00 p.m. on January 27, 2020 with the MLT Supervisor confirmed the laboratory failed to re-order the Proficiency Testing for 2020. ===================================== -- 2 of 3 -- D6053 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) The technical consultant is responsible for evaluating and documenting the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tests patient specimens. This STANDARD is not met as evidenced by: ===================================== Based on lack of training and semi-annual competency documentation for Medical Laboratory Technician #1, hire date 10/29/2018, and an interview with the MLT Supervisor, it was determined the Technical Consultant failed to document training and semi-annual competency performance for Chemistry, Hematology, KOH (Potassium Hydroxide) and Wet Prep Analysis testing since hire date. The findings include: 1. No training and/or semi- annual competencies documented for MLT #1 for performing Chemistry, Hematology, KOH and Wet Prep Analysis testing since hire date of 10/29/2018. 2. An interview with the MLT Supervisor at approximately 3:00 p.m. on January 27, 2020 confirmed there was no documentation of training and/or semi-annual competency for MLT #1 since hire date 10/29/2018. ===================================== D6054 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) The technical consultant is responsible for evaluating and documenting the performance of individuals responsible for moderate complexity testing at least annually, after the first year. This STANDARD is not met as evidenced by: ==================================== Based on lack of annual competency documentation for Medical Laboratory Technician (MLT) number 1 and MLT number 3 and Medical Technologist (MT) number 4 and an interview with the MLT Supervisor, it was determined the Technical Consultant failed to document annual competency performance for Chemistry, Hematology, KOH (Potassium Hydroxide) and Wet Prep Analysis testing for 2019. The findings include: 1. The Technical Consultant failed to document annual competencies for MLT's number 1 and 3 and MT number 4, for performance of Chemistry, Hematology, KOH and Wet Prep Analysis testing for 2019. 2. An interview with the MLT Supervisor at approximately 3:00 p.m. on January 27, 2020 confirmed that 2019 annual competencies had not been documented. ===================================== -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 5, 2019

Survey Type: Special

Survey Event ID: OU5W11

Deficiency Tags: D2061 D2016

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: ==================================== VIROLOGY: The laboratory failed to maintain satisfactory participation in two out of two events for Virology, resulting in the first unsuccessful proficiency testing (PT) occurrence for Virology (Refer to D2061). ==================================== D2061 VIROLOGY CFR(s): 493.831(c) Failure to return proficiency testing results to the proficiency testing program within Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- the time frame specified by the program is unsatisfactory performance and results in a score of 0 for the testing event. This STANDARD is not met as evidenced by: ===================================== Based on the May 2019 CASPER Report 0155D Proficiency Testing (PT) results which showed 0% scores for 2018-3rd event and 2019-1st event for Virology and upon phone interview with Laboratory Supervisor, determined the laboratory failed to return proficiency testing results within the time frame specified by the program and received unsatisfactory scores resulting in the 1st unsuccessful occurrence. The findings include: 1. The May 2019 CASPER Report 0155D Proficiency Testing (PT) results showed 0% scores for 2018- 3rd event and 2019-1st event for Virology. 2. Phone interview at approximately 10:00 a.m. May 9, 2019 with Laboratory Supervisor confirmed the laboratory failed to send in results for Virology (Influenza A and B) prior to PT program time frame for the 3rd event of 2018 and the 1st event of 2019 resulting in 0% scores and the 1st unsuccessful Proficiency Testing occurrence for Virology. ====================================== -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access